Epidemiological and virological features of HBV infection in HIV-2 infected patients living in southeastern France

European Journal of Epidemiology

Volumn 21, Issue 8, 2006, Pages 615-618

  Colson, Philippe ^a   Henry, Mireille ^a,b   Motte, Anne ^a,b   Gallais, Hervé ^c   Moreau, Jacques ^d   Poizot Martin, Isabelle ^e   Tamalet, Catherine ^a,b  

^a TIMONE HOSPITAL   (France)

^b CNRS   (France)

^c HÔPITAL DE LA CONCEPTION   (France)

^d HÔPITAL NORD   (France)

^e HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

HBsAg mutants; HBV genotype E; HBV infection diagnosis; HBV HIV co infection; HIV 2

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; EUROPE; FOLLOW UP; FRANCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; VIRUS DIAGNOSIS;

ADULT; AGED; DNA, VIRAL; FEMALE; FRANCE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HIV INFECTIONS; HIV-2; HUMANS; MALE; MIDDLE AGED;

EID: 33749628882     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9039-4     Document Type: Article

References (12)

1. Konopnicki D, Mocroft A, de Wit S, et al. 2005; Hepatitis B and HIV: Prevalence, AIDS progression, response to highly active antiretroviral therapy and increased mortality in the EuroSIDA cohort. AIDS 19(6):593-601
2. Ejele OA, Nwauche CA, Erhabor O, 2004; The prevalence of hepatitis B surface antigenaemia in HIV positive patients in the Niger Delta Nigeria. Niger J Med 13(2):175-179
3. Mulders MN, Venard V, Njayou M, et al. Low genetic diversity despite hyperendemicity of hepatitis B virus genotype E throughout West Africa. J Infect Dis 2004; 190(2): 400-408. Epub 2004 Jun 22
4. Rouet F, Chaix ML, Inwoley A, et al. 2004; HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Cote d'Ivoire: The ANRS 1236 study. J Med Virol 74(1):34-40
5. Reeves JD, Doms RW, 2000; Human immunodeficiency virus type 2. J Gen Virol 83(Pt 6):1253-1265
6. Colson P, Henry M, Tivoli N, et al. 2005; Polymorphism and drug-selected mutations in the reverse transcriptase gene of HIV-2 from patients living in southeastern France. J Med Virol 75(3):381-390
7. Delfraissy JF, Epidémiologie. In: Flammarion M-S (ed), Prise en charge thérapeutique des personnes infectées par le VIH: Recommandations du groupe d'experts. 2004: 17-42
8. Gerolami R, Henry M, Borentain P, Colson P, Botta D, Tamalet C. Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment. Clin Infect Dis 2005; 40(4):e24-27. Epub 2005 Jan 21
9. Hunt CM, McGill JM, Allen MI, Condreay LD., 2000; Clinical relevance of hepatitis B viral mutations. Hepatology 31(5):1037-1044
10. Matheron S, Pueyo S, Damond F, et al. 2003; Factors associated with clinical progression in HIV-2 infected-patients: The French ANRS cohort. AIDS 17(18):2593-2601
11. Koyanagi T, Nakamuta M, Sakai H, et al. 2000; Analysis of HBs antigen negative variant of hepatitis B virus: Unique substitutions, Glu129 to Asp and Gly145 to Ala in the surface antigen gene. Med Sci Monit 6(6):1165-1169
12. Protzer-Knolle U, Naumann U, Bartenschlager R, et al. 1998; Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27(1):254-263